Accuray 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Jan 27Expected
Q3 2026
Next
-2.55
-0.87
0.81
2.49
Expected EPS
-2.551948
Actual EPS
N/A

Financials

-12.16%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
346.22MRevenue
-42.11MNet Income

Analyst Ratings

$0.00Average Price Target
The highest estimate is ⁦0.00⁩.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XEJ0.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Elekta AB
EKTAY
Mkt Cap2B
Elekta provides radiotherapy and radiosurgery systems, directly competing with Accuray in the precision radiation therapy market.
Intuitive Surgical
ISRG
Mkt Cap153.77B
Intuitive Surgical, known for its da Vinci surgical systems, competes in the broader market of surgical interventions, including those where Accuray's radiosurgery systems could be used.
Medtronic
MDT
Mkt Cap131.57B
Medtronic offers products in the medical devices sector, including surgical and radiotherapy equipment, competing with Accuray in the market for medical treatments.
Zimmer Biomet
ZBH
Mkt Cap19.53B
Zimmer Biomet, while primarily focused on orthopedics, competes in the medical device market, offering products that can be in direct or indirect competition with Accuray's solutions.
Boston Scientific
BSX
Mkt Cap64.27B
Boston Scientific competes in the medical devices market, offering a range of products that can indirectly compete with Accuray's therapeutic devices.
Smith & Nephew
SNN
Mkt Cap13.09B
Smith & Nephew, a medical technology company, competes in the broader medical devices market, potentially overlapping with Accuray's market in surgical solutions.
Stryker
SYK
Mkt Cap117.88B
Stryker is a medical technologies firm that, among other areas, competes in the surgical equipment space, potentially overlapping with Accuray's offerings.
Globus Medical
GMED
Mkt Cap9.57B
Globus Medical, primarily focused on spine and orthopedic solutions, competes in the medical device market, which includes surgical and therapeutic devices similar to Accuray's.
Integra Lifesciences
IART
Mkt Cap1.12B
Integra LifeSciences, offering products in surgery, neurosurgery, and orthopedics, competes in the broader market of medical devices, including areas where Accuray's technologies are used.

About

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
Show More
CEO
Employees
809
Country
United States
ISIN
US0043973033
WKN
000A42QTM

Listings

0 Comments

Share your thoughts

FAQs

What is Accuray stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Accuray stocks are traded under the ticker XEJ0.F.
When is the next Accuray earnings date?▼
Accuray is going to release the next earnings report on January 27, 2027.
What were Accuray earnings last quarter?▼
XEJ0.F earnings for the last quarter are 2.49 EUR per share, whereas the estimation was -2.49 EUR resulting in a +200% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Accuray revenue for the last year?▼
Accuray revenue for the last year amounts to 346.22M EUR.
What is Accuray net income for the last year?▼
XEJ0.F net income for the last year is -42.11M EUR.
How many employees does Accuray have?▼
As of November 19, 2026, the company has 809 employees.
In which sector is Accuray located?▼
Accuray operates in the Other sector.
When did Accuray complete a stock split?▼
The last stock split for Accuray was on November 9, 2026 with a ratio of 1:40.
Where is Accuray headquartered?▼
Accuray is headquartered in MADISON, United States.